The role of pyroptosis in cancer: pro-cancer or pro-“host”?
Open Access
- 9 September 2019
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 10 (9), 1-13
- https://doi.org/10.1038/s41419-019-1883-8
Abstract
Programmed cell death (PCD) refers to the way in which cells die depending on specific genes encoding signals or activities. Apoptosis, autophagy, and pyroptosis are all mechanisms of PCD. Among these mechanisms, pyroptosis is mediated by the gasdermin family, accompanied by inflammatory and immune responses. The relationship between pyroptosis and cancer is complex, and the effects of pyroptosis on cancer vary in different tissues and genetic backgrounds. On one hand, pyroptosis can inhibit the occurrence and development of tumors; on the other hand, as a type of proinflammatory death, pyroptosis can form a suitable microenvironment for tumor cell growth and thus promote tumor growth. In addition, the induction of tumor pyroptosis is also considered a potential cancer treatment strategy. Studies have shown that DFNA5 (nonsyndromic hearing impairment protein 5)/GSDME (Gasdermin-E) mRNA methylation results in lower expression levels of DFNA5/GSDME in most tumor cells than in normal cells, making it difficult to activate the pyroptosis in most tumor cells. During the treatment of malignant tumors, appropriate chemotherapeutic drugs can be selected according to the expression levels of DFNA5/GSDME, which can be upregulated in tumor cells, thereby increasing the sensitivity to chemotherapeutic drugs and reducing drug resistance. Therefore, induced pyroptosis may play a predominant role in the treatment of cancer. Here, we review the latest research on the anti- and protumor effects of pyroptosis and its potential applications in cancer treatment.Keywords
This publication has 128 references indexed in Scilit:
- Evidence For Multiple Cell Death Pathways during Development of Experimental Cytomegalovirus Retinitis in Mice with Retrovirus-Induced Immunosuppression: Apoptosis, Necroptosis, and PyroptosisJournal of Virology, 2012
- The Nlrp3 inflammasome: contributions to intestinal homeostasisTrends in Immunology, 2011
- Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4Proceedings of the National Academy of Sciences of the United States of America, 2010
- Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteriaNature Immunology, 2010
- Inflammatory Stimuli Regulate Caspase Substrate ProfilesMolecular & Cellular Proteomics, 2010
- The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancerThe Journal of Experimental Medicine, 2010
- The HSV-2 mutant ΔPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteinsGene Therapy, 2009
- Pyroptosis: host cell death and inflammationNature Reviews Microbiology, 2009
- Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancerBiochemical and Biophysical Research Communications, 2008
- Differential expression and localisation of gasdermin-like (GSDML), a novel member of the cancer-associated GSDMDC protein family, in neoplastic and non-neoplastic gastric, hepatic, and colon tissuesPathology, 2008